Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Risk factors for ovarian cancers with and without microsatellite instability.

Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Sun P, Narod SA, Schildkraut J.

Int J Gynecol Cancer. 2014 May;24(4):664-9. doi: 10.1097/IGC.0000000000000134.

PMID:
24755492
2.

Risk factors for ovarian cancers with and without microsatellite instability.

Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Ping S, Narod SA, Schildkraut J.

Int J Gynecol Cancer. 2013 Jul;23(6):1010-5. doi: 10.1097/IGC.0b013e31829a5527. Retraction in: Beller U. Int J Gynecol Cancer. 2014 Sep;24(7):1356.

3.

Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?

Reitsma W, de Bock GH, Oosterwijk JC, ten Hoor KA, Hollema H, Mourits MJ.

Int J Gynecol Cancer. 2012 May;22(4):579-85. doi: 10.1097/IGC.0b013e31823d1b5c.

PMID:
22274543
4.
5.

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.

6.

Risk factors for different histological types of ovarian cancer.

Parazzini F, Chiaffarino F, Negri E, Surace M, Benzi G, Franceschi S, Fedele L, La Vecchia C.

Int J Gynecol Cancer. 2004 May-Jun;14(3):431-6.

PMID:
15228415
7.

Circulating prolactin levels and risk of epithelial ovarian cancer.

Clendenen TV, Arslan AA, Lokshin AE, Liu M, Lundin E, Koenig KL, Berrino F, Hallmans G, Idahl A, Krogh V, Lukanova A, Marrangoni A, Muti P, Nolen BM, Ohlson N, Shore RE, Sieri S, Zeleniuch-Jacquotte A.

Cancer Causes Control. 2013 Apr;24(4):741-8. doi: 10.1007/s10552-013-0156-6. Epub 2013 Feb 3.

8.

Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.

Huusom LD, Frederiksen K, Høgdall EV, Glud E, Christensen L, Høgdall CK, Blaakaer J, Kjaer SK.

Cancer Causes Control. 2006 Aug;17(6):821-9.

PMID:
16783610
9.

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group.

Lancet Oncol. 2007 Jan;8(1):26-34.

PMID:
17196508
10.

Low-dose aspirin use and the risk of ovarian cancer in Denmark.

Baandrup L, Kjaer SK, Olsen JH, Dehlendorff C, Friis S.

Ann Oncol. 2015 Apr;26(4):787-92. doi: 10.1093/annonc/mdu578. Epub 2014 Dec 23.

PMID:
25538177
11.

Histologic types of epithelial ovarian cancer: have they different risk factors?

Kurian AW, Balise RR, McGuire V, Whittemore AS.

Gynecol Oncol. 2005 Feb;96(2):520-30.

PMID:
15661246
12.

Parkin gene alterations in ovarian carcinoma from northern Indian population.

Mehdi SJ, Ali A, Rizvi MM.

Pathol Oncol Res. 2011 Sep;17(3):579-86. doi: 10.1007/s12253-010-9351-x. Epub 2011 Jan 10.

PMID:
21221875
13.

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

Narod SA, Sun P, Ghadirian P, Lynch H, Isaacs C, Garber J, Weber B, Karlan B, Fishman D, Rosen B, Tung N, Neuhausen SL.

Lancet. 2001 May 12;357(9267):1467-70.

PMID:
11377596
14.

Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository.

Matsuno RK, Sherman ME, Visvanathan K, Goodman MT, Hernandez BY, Lynch CF, Ioffe OB, Horio D, Platz C, Altekruse SF, Pfeiffer RM, Anderson WF.

Cancer Causes Control. 2013 Apr;24(4):749-57. doi: 10.1007/s10552-013-0157-5. Epub 2013 Feb 3.

15.

Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer.

Nielsen JS, Jakobsen E, Hølund B, Bertelsen K, Jakobsen A.

Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1086-96.

PMID:
15571614
16.

Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.

Jensen KC, Mariappan MR, Putcha GV, Husain A, Chun N, Ford JM, Schrijver I, Longacre TA.

Am J Surg Pathol. 2008 Jul;32(7):1029-37. doi: 10.1097/PAS.0b013e31816380c4.

PMID:
18469706
17.

Body mass index and risk of ovarian cancer.

Leitzmann MF, Koebnick C, Danforth KN, Brinton LA, Moore SC, Hollenbeck AR, Schatzkin A, Lacey JV Jr.

Cancer. 2009 Feb 15;115(4):812-22. doi: 10.1002/cncr.24086.

18.

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.

Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298.

PMID:
25025451
19.

Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.

Wenham RM, Schildkraut JM, McLean K, Calingaert B, Bentley RC, Marks J, Berchuck A.

Clin Cancer Res. 2003 Oct 1;9(12):4396-403.

20.

Epidemiologic features of borderline ovarian tumors in California: a population-based study.

Morris CR, Liu L, Rodriguez AO, Cress RD, Snipes K.

Cancer Causes Control. 2013 Apr;24(4):665-74. doi: 10.1007/s10552-013-0145-9. Epub 2013 Jan 13.

PMID:
23314731
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk